Abraham Manoj T, Husain Solomon, Wong Anni, Gidumal Sunder, Elahi Ebrahim, Marmur Ellen, DelMauro Matthew
Aesthet Surg J Open Forum. 2025 Jan 16;7:ojaf005. doi: 10.1093/asjof/ojaf005. eCollection 2025.
There are many published studies that indicate neuromodulators help improve surgical outcomes and the appearance of facial scars.
To determine the prevalence of neuromodulator use as an adjunct for facial scar treatment as well as blepharoplasty and brow lift surgeries across surgical subspecialties.
An anonymous electronic survey was distributed to plastic surgeons, facial plastic surgeons, oculoplastic surgeons, and dermatologic surgeons through their respective national societies. The survey assessed demographics, practice characteristics, and practice habits.
A total of 276 surgeons responded. Although 96.7% of respondents use neuromodulators in their practice, only 21% utilize neuromodulators for scar optimization, and 12.3% and 25.4% utilize neuromodulators for optimization of blepharoplasty and surgical brow lift outcomes, respectively.
Although the use of neuromodulators has been shown to improve the appearance of scars and could enhance outcomes after blepharoplasty and brow lift procedures, its use among respondents was limited.
有许多已发表的研究表明,神经调节剂有助于改善手术效果和面部疤痕外观。
确定在各个外科亚专业中,将神经调节剂用作面部疤痕治疗以及眼睑成形术和提眉手术辅助手段的使用情况。
通过各自的全国性学会,向整形外科医生、面部整形外科医生、眼整形医生和皮肤科外科医生发放了一份匿名电子调查问卷。该调查评估了人口统计学、执业特征和执业习惯。
共有276名外科医生回复。尽管96.7%的受访者在其执业中使用神经调节剂,但只有21%的人将神经调节剂用于疤痕优化,分别有12.3%和25.4%的人将神经调节剂用于优化眼睑成形术和手术提眉效果。
尽管已证明使用神经调节剂可改善疤痕外观,并可提高眼睑成形术和提眉手术后的效果,但在受访者中其使用有限。